By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gulf PressGulf Press
  • Home
  • Gulf News
    • Saudi Arabia
    • UAE24/7
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • World
  • Business
    • Market DataLive
    • Finance
    • Economy
    • Energy
    • Crypto
    • ForexHot
    • Tech
  • Sports
  • Lifestyle
  • Videos
Search
Countries
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Bahrain
  • Oman
More Topics
  • Technology
  • Health
  • Entertainment
  • Crypto
  • Forex
  • Stocks
Site Links
  • Business Hub
  • Trending
  • Weather
  • Customize Interests
  • Bookmarks
  • Newsletter
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Reading: Which is superior: Semaglutide or Tirzepatide?
Share
Notification Show More
Recent Saved
Workers in Bucharest face challenges as temperatures rise
World
Dress code guidelines for the Qatari government sector during office hours
Qatar
Court rules in favor of worker after company dismisses him for salary deductions over 6 years, awarding BD 27,000.
Bahrain
UAE to See Almost 30,000 New Millionaires in 5 Years
UAE
Proposed New Labor Law in Bahrain Targets Increasing Job Opportunities
Bahrain
Latest News
Ferrero’s Social Responsibility Project Kinder Joy of moving Beats Traditional PE Curriculum, Tapping into the Cognitive Functions, Motor Coordination and Life Skills of Students
Lifestyle
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech
Beat the Heat This Summer with a Chill Out on Dubai Marina
World
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World
Jordan to Host Iraq in the Final Round of the Asian World Cup Qualifiers After Securing Historic Spot
Sports
The Myriad Redefines Student Living for a Mobile, Urban Generation
UAE
L’Oréal Paris Welcomes Yasmine Sabri as New Brand Ambassador for the Middle East
Lifestyle
Roland Garros 2025: A New Era of Viewing, A Tribute to Legends, and Moments to Remember
Sports World
Bitget Celebrates Bitcoin Pizza Day by Distributing Over 5000 Pizzas in Over 20 Cities Worldwide
Crypto
Bitget Protection Fund Maintains Strength with $561 Million Average Value in April 2025
Business Crypto
Moscow Metro Marks 90 Years with Technological Advancements and Heritage Events
Lifestyle World
Senkron Digital Showcases CyberPact Service at GISEC Global 2025
Gulf UAE
Muhammad Umair Saeed: The Billionaire Tech Architect Powering AI, Drones, Blockchain & Cybersecurity from Dubai to the World
Business Gulf UAE
Barcelona Aims to Recover from European Heartbreak as They Face Real Madrid in La Liga, Chasing Their Third Title of the Season
Sports
UAE with 47% and Qatar with 36% Surge in Viewing Minutes as TOD Unveils its Enhanced Streaming Experience TOD 2.0
Lifestyle
L’Oréal Paris Celebrates the Groundbreaking Launch of MELASYL at the Iconic Museum of the Future
Lifestyle
TOD Partners with Skyworth’s QVWi to Launch 4K Streaming Set-Top Box in MENA
Gulf Sports
Double victory at Red Dot: Eczacıbaşı Tiles Group’s VitrA and Villeroy & Boch brands recognised for their design excellence
Lifestyle
Your Next Destination in Dubai: Mövenpick Hotel Apartments Downtown Dubai – The Perfect Choice for Your Stay
Gulf UAE
Aa
Gulf PressGulf Press
Aa
  • Gulf News
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Videos
Search
  • Home
    • Videos
    • Business Hub
    • Trending
  • Gulf
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • Business
    • Market Data
    • Crypto
    • Economy
    • Energy
    • Finance
    • Forex
    • Tech
  • More News
    • World
    • Lifestyle
    • Entertainment
    • Sports
Have an existing account? Sign In
Follow US
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Gulf Press > Health > Which is superior: Semaglutide or Tirzepatide?
Health

Which is superior: Semaglutide or Tirzepatide?

News Room
Last updated: 2024/07/10 at 4:04 PM
News Room
Share
4 Min Read
SHARE

Weight loss can be a challenging journey, especially for individuals struggling with obesity or overweight. However, recent research has shown promising results for two medications, tirzepatide and semaglutide, in assisting with weight loss in individuals with type 2 diabetes and other related conditions. A study published in JAMA Internal Medicine compared the effectiveness of these two medications and found that tirzepatide was more effective in helping participants lose weight compared to semaglutide. This new data is essential in understanding the benefits of these medications and may influence clinical guidelines in the future.

Tirzepatide and semaglutide are both FDA-approved medications for certain eligible individuals looking to manage chronic weight issues. While both medications have shown some effectiveness in weight loss, the recent study revealed that tirzepatide was more successful in helping participants achieve significant weight loss. Researchers found that a higher percentage of individuals taking tirzepatide experienced 5% or greater weight loss compared to those taking semaglutide. Additionally, tirzepatide was also more effective in helping patients achieve 10% and 15% weight loss within a year, irrespective of whether they had type 2 diabetes or not.

Despite the positive results of the study, there are some limitations that need to be considered. The study focused on a primarily white and female cohort, which may not represent the general population accurately. Additionally, the study relied on information from electronic health records, which could result in under-reported adverse events and other biases. Moreover, over half of the participants discontinued the medications during the study, which could affect the overall findings. Future research may address these limitations and provide a more comprehensive understanding of the effectiveness of tirzepatide and semaglutide in weight management.

The study’s findings have significant implications for healthcare providers and individuals interested in pursuing weight loss medications. While tirzepatide was shown to be more effective than semaglutide, other factors such as medication availability, insurance coverage, and individual patient characteristics should also be considered when deciding on the most suitable treatment option. Individuals seeking weight loss medications should consult with their healthcare providers to assess their eligibility, potential risks, and benefits associated with these medications.

The study’s authors also highlighted the need for further research to explore the long-term effects and clinical outcomes of tirzepatide and semaglutide. Understanding the barriers to equitable access, trends in prescriptions and dispensing, and the impact of medication discontinuation are essential for optimizing the use of these medications in weight management. By gaining a more in-depth understanding of these medications, healthcare providers can better guide their patients in choosing the most appropriate treatment for their individual needs.

Overall, the study comparing tirzepatide and semaglutide in weight loss provides valuable insights into the effectiveness of these medications for individuals with obesity or overweight. With further research and ongoing monitoring of trends in their prescriptions and usage, healthcare providers can make more informed decisions about recommending these medications to patients seeking to achieve their weight loss goals. Ultimately, a multi-disciplinary approach that includes medication, diet, exercise, and lifestyle changes can be instrumental in helping individuals achieve sustainable weight loss and improve their overall health and well-being.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room July 10, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Microsoft and Apple step down from observer positions on OpenAI board – News
Next Article Jabal Real Estate Investment Fund is now listed on the Muscat Stock Exchange.
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
136k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

Ferrero’s Social Responsibility Project Kinder Joy of moving Beats Traditional PE Curriculum, Tapping into the Cognitive Functions, Motor Coordination and Life Skills of Students
Lifestyle July 14, 2025
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports July 6, 2025
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech July 1, 2025
Beat the Heat This Summer with a Chill Out on Dubai Marina
World July 1, 2025

You Might also Like

Health

Mindfulness could be equally effective as antidepressants

October 17, 2024
Health

What is the impact of caffeine on the risk of developing diseases?

October 17, 2024
Health

Scientists discover combination of 14 genes that enhance outcomes

October 16, 2024
Health

Seizure medication demonstrates potential in individuals with no genetic risk

October 16, 2024
Health

Heart disease increases risk, heparin can postpone onset

October 16, 2024
Health

What type of breakfast is most effective for weight loss in women compared to men?

October 15, 2024
Health

How does the brain remove “waste” to protect itself?

October 14, 2024
Health

How does stress, sleep, and gut imbalances affect it?

October 13, 2024
//

Gulf Press is your one-stop website for the latest news and updates about Arabian Gulf and the world, follow us now to get the news that matters to you.

Quick Link

  • Privacy Policy
  • Terms of ue
  • Advertise
  • Contact

How Topics

  • Gulf News
  • International
  • Business
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our latest news instantly!

I have read and agree to the terms & conditions
Gulf PressGulf Press
Follow US

© 2023 Gulf Press. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?